PPP2R5C expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.419200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.772000E-01
Normal-vs-Stage2
4.978800E-01
Normal-vs-Stage3
2.872200E-01
Normal-vs-Stage4
7.521600E-01
Stage1-vs-Stage2
5.644000E-01
Stage1-vs-Stage3
4.228400E-01
Stage1-vs-Stage4
6.393600E-01
Stage2-vs-Stage3
2.073800E-01
Stage2-vs-Stage4
9.145600E-01
Stage3-vs-Stage4
4.005800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.669400E-01
Normal-vs-AfricanAmerican
3.769400E-01
Normal-vs-Asian
3.596200E-01
Caucasian-vs-AfricanAmerican
4.789200E-01
Caucasian-vs-Asian
3.209600E-01
AfricanAmerican-vs-Asian
9.721000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.122600E-01
Normal-vs-Female
3.884400E-01
Male-vs-Female
4.389600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.677800E-01
Normal-vs-Age(41-60Yrs)
7.277800E-01
Normal-vs-Age(61-80Yrs)
3.665600E-01
Normal-vs-Age(81-100Yrs)
4.198600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.160800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.006800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.029800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.518400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.037000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.803600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.839200E-01
Normal-vs-Daily Drinker
5.031400E-01
Normal-vs-Weekly Drinker
1.744600E-01
Normal-vs-Occasional Drinker
7.383800E-01
Normal-vs-Social Drinker
6.647000E-01
Non Drinker-vs-Daily Drinker
9.063800E-01
Non Drinker-vs-Weekly Drinker
4.250600E-01
Non Drinker-vs-Occasional Drinker
4.548800E-01
Non Drinker-vs-Social Drinker
4.900200E-01
Daily Drinker-vs-Weekly Drinker
3.543200E-01
Daily Drinker-vs-Occasional Drinker
5.681200E-01
Daily Drinker-vs-Social Drinker
5.577200E-01
Weekly Drinker-vs-Occasional Drinker
5.939800E-02
Weekly Drinker-vs-Social Drinker
1.039210E-01
Occasional Drinker-vs-Social Drinker
8.696600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.853790E-01
Normal-vs-Grade 2
2.903800E-02
Normal-vs-Grade 3
4.914300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.424600E-01
Grade 1-vs-Grade 3
2.486800E-01
Grade 1-vs-Grade 4
1.853790E-01
Grade 2-vs-Grade 3
4.974000E-01
Grade 2-vs-Grade 4
2.903800E-02
Grade 3-vs-Grade 4
4.914300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.579400E-01
Normal-vs-NonDiabetic
3.309600E-01
Diabetic-vs-NonDiabetic
3.751400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.578760E-01
Normal-vs-NoPancreatitis
4.510600E-01
Pancreatitis-vs-NoPancreatitis
2.262600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.475800E-01
Normal-vs-N1
4.735600E-01
N0-vs-N1
6.371800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.902400E-01
Normal-vs-TP53-NonMutant
7.748400E-01
TP53-Mutant-vs-TP53-NonMutant
1.365370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
